Showing results (2041-2050 of 2,091) with videos related to

Sort By:
Pageof 210
Antimicrobial Agents and Chemotherapy|January 11, 2012
Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) studySo Hyun Kim, Jae-Hoon Song, Doo Ryeon Chung, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase InhibitorsDerun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.
Acta Cardiologica Sinica|May 31, 2018
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in TaiwanYi-Heng Li, Chih-Yuan Fang, I-Chang Hsieh, et al.
Horticulture Research|May 23, 2024
Coping with alpine habitats: genomic insights into the adaptation strategies of Triplostegia glandulifera (Caprifoliaceae)Jian Zhang, Kai-Lin Dong, Miao-Zhen Ren, et al.
The American Journal of Gastroenterology|January 19, 2005
Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal casesXueying Shi, Encong Gong, Dongxia Gao, et al.
Theranostics|January 6, 2022
Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtypeSheng-Qing Lv, Zhen Fu, Lin Yang, et al.
The Lancet. Global Health|August 16, 2024
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysisTrishul Siddharthan, Kyle Grealis, Nicole M Robertson, et al.
Blood Advances|May 7, 2025
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosisDavid M Ross, Florian H Heidel, Andrew C Perkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I TrialIngo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
Pageof 210